โ† All deals

ROCKET PHARMACEUTICALS, INC.

Public Equity (NASDAQ)BiotechnologyGene TherapyPublic Company
๐Ÿ“ Cranbury, New Jersey, United Statesโ€ข Founded 2015
StreetZero Signal 44
Be the first to signal interest

About ROCKET PHARMACEUTICALS, INC.

Rocket Pharmaceuticals, Inc. is a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening disorders. The company focuses on developing gene therapies that correct the root cause of complex and rare childhood diseases through an integrated pipeline. It operates as a public company on NASDAQ under the ticker RCKT and is headquartered in Cranbury, New Jersey.

LATEST FUNDINGRule 144
$1K
Announced 2026-11-18
TOTAL RAISED$1.06B
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for ROCKET PHARMACEUTICALS, INC..

Free plan includes 3 full deal profiles every month.

Key highlights

  • Raised $1.06B total across 16 funding rounds with prominent life science investors.
  • RTW Investments led Series A and B and took the company public via reverse merger in 2018.
  • Completed a $26.4M private placement in 2021 to advance its gene therapy pipeline.
  • Secured up to $150M credit facility from Hercules Capital to support cardiovascular programs.
  • Operates with no debt on balance sheet, relying on shareholder funding for its late-stage biotech activities.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account